Categories
News

Moderna-backed Metagenomi cuts US IPO valuation target to $563 million – Times of India

Estimated read time 1 min read

[ad_1] Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO), […]

Trending

Error: View 5202f4313c may not exist